This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information
The new surrogate virus neutralisation test for the determination of neutralising antibodies supplements our CE-marked QuantiVac ELISA and the SARS-CoV-2 IGRA* to support the evaluation of the immune response to SARS-CoV-2 after infection or vaccination with a S1/RBD-based vaccine.
*For research use only, not for in vitro diagnostics in the sense of EU Directive 98/79/EC
EUROPattern Microscope Live is an ultrafast and fully automated immunofluorescence system. The enormous speed of the image processing is complemented by the high comfort of the user software EUROLabOffice 4.0 for evaluation of the immunofluorescence images directly on the computer screen.
moreThe new test system (IGRA) enables to determine the activity of SARS-CoV-2 reactive T-cells and is helpful in research studies evaluating the cellular immune response to SARS-CoV-2 in the context of infections or vaccination.
*For research use only, not for in vitro diagnostics in the sense of EU Directive 98/79/EC
On time for the flu season: With the EURORealTime SARS-CoV-2/Influenza A/B EUROIMMUN offers a new combination test for differential diagnostic clarification of symptoms that can be associated with influenza as well as COVID-19.
websiteNew ELISA for quantitative detection of antibodies against viral S1 antigen. The ELISA is the first antibody test to allow quantification of antibody concentration in standardised units (BAU/ml). This can be a valuable support for assessment of individual immune responses to SARS-CoV-2 after infection or vaccination.
websiteThe detection of antibodies against SARS-CoV-2 is now also possible in dried capillary blood (dried blood spots – DBS). In addition to the ELISAs (CE-IVD) for determination of IgG antibodies against viral S1 and NCP, EUROIMMUN also offers a suitable CE-marked blood collection set for collection and mailing of dried capillary blood samples. It is suitable either for personal use in a home-use environment, or for blood collection performed by a healthcare professional.
websiteFaster and more reliable detection of dermatomycosis pathogens.
Dermatomycoses are infections of the skin, hair and nails, which are caused in most cases by dermatophytes, and in rarer cases by yeasts and moulds. Fungal infections of the skin are the most frequently occurring infectious diseases, with a worldwide prevalence of 20% to 25% and high and growing relapse rates.
WebsiteMoulds of the genus Aspergillus are present in the air and soil, but also in biological waste and contaminated foods. Within the genus, which encompasses more than 300 species, some may lead to infections in humans, given the respective predisposition. Here, Aspergillus fumigatus plays an especially important role.
moreThe diagnosis of acute glomerulonephritis.
The sCD163 ELISA is particularly suited for monitoring patients with diagnosed AAV with renal involvement. Contrary to systemic inflammation markers, the sCD163 level is a specific indicator of renal inflammation and reacts quickly under treatment or in case of fluctuations in the inflammatory activity.
moreEUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies
EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response
Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected COVID-19-Patients
New PCR test to differentiate between COVID-19 and flu
Novel ELISA for Quantification of Antibodies against S1 Protein of SARS-CoV-2
INOCHEM becomes part of EUROIMMUN family
EURORealTime SARS-CoV-2 approved by the FDA via an Emergency Use Authorization
SARS-CoV-2 Testing from EUROIMMUN
FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies
EUROIMMUN now offers a complete test package for direct detection of the new coronavirus and antibodies against SARS-CoV-2
Tests for detection of antibodies against SARS-CoV-2 now available
A new German law on mandatory measles vaccination
Fast and reliable detection of dermatomycosis pathogens
The Immunoblot PreQ System
EUROIMMUN Calprotectin ELISA
EUROArray HPV: More certainty in the early diagnosis of cervical cancer
Anti-MERS-CoV ELISA and IIFT: First commercial tests worldwide for the determination of antibodies against MERS coronavirus in humans and camels.
Reliable diagnosis of dengue virus infections in all disease stages
Anti-Borrelia EUROLINE-RN-AT-adv: highest specificity for borreliosis diagnostics through OspC advanced
Designer antigens – customised for laboratory diagnostics
Recombinant Cell IFT (RC-IIFT) – the quickest way to bring new research parameters into the diagnostic laboratory
EUROPattern: Software for image capturing and interpretation of IIFT patterns in autoimmune diagnostics
New products for Chlamydia diagnostics
Anti-NMDA receptor encephalitis: Recombinant immunofluorescence test for determination of antibodies against glutamate receptors
EUROIMMUN 25-OH Vitamin D ELISA: a reliable, convenient test